WO2023214433 - STABLE PARENTERAL COMPOSITIONS OF PARECOXIB
National phase entry is expected:
Publication Number
WO/2023/214433
Publication Date
09.11.2023
International Application No.
PCT/IN2023/050429
International Filing Date
04.05.2023
Title **
[English]
STABLE PARENTERAL COMPOSITIONS OF PARECOXIB
[French]
COMPOSITIONS PARENTÉRALES STABLES DE PARÉCOXIB
Applicants **
INVENTIA HEALTHCARE LIMITED
Unit 703 & 704, 7th floor, Hubtown Solaris, N. S. Phadke Marg, Andheri (East), Mumbai, Maharashtra, India
Mumbai 400069, IN
Inventors
SHAH, Vaibhavi
30, “Saujanya”, Vallabhnagar Society, 3rd N. S. Road, JVPD Scheme, Vile Parle (West), Mumbai, Maharashtra, India
Mumbai 400056, IN
SANKALIA, Mayurbhai
87, Adarsh Duplex, Gorwa, Vadodara, Gujarat, India
Vadodara 390016, IN
BORHADE, Pradnya
A1/703, Nanadanvan Homes, Parsik Nagar, Kalwa, Thane (West), Maharashtra, India
Kalwa 400605, IN
Priority Data
202221026135
05.05.2022
IN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
IP India
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 1074 | |
| EPO | Filing, Examination | 6428 | |
| Japan | Filing | 595 | |
| South Korea | Filing | 574 | |
| USA | Filing, Examination | 2710 |
Total: 11381 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
The present invention relates to stable, lyophilized compositions comprising parecoxib, for parenteral administration. The lyophilized compositions are capable of being reconstituted in a suitable reconstitution diluent to obtain liquid parecoxib compositions, the said liquid compositions having an in-use stability of at least 48 hours. The invention provides a process for preparation of the said compositions.[French]
La présente invention concerne des compositions lyophilisées stables comprenant du parécoxib, pour une administration parentérale. Les compositions lyophilisées peuvent être reconstituées dans un diluant de reconstitution approprié pour obtenir des compositions de parécoxib liquide, lesdites compositions liquides ayant une stabilité d'utilisation d'au moins 48 heures. L'invention concerne un procédé de préparation desdites compositions.